gene therapy

Novartis to Buy AveXis in $8B Gene Therapy Bet
Strategy

Novartis to Buy AveXis in $8B Gene Therapy Bet

The deal gives the Swiss drugmaker a neurological disease treatment that may have "a multi-billion dollar peak sales potential."
By Matthew Heller | April 9, 2018
Read More